Page last updated: 2024-08-21

dronabinol and Angiogenesis, Pathologic

dronabinol has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, SS; Jung, Y; Kang, Y; Kim, JA; Ku, SK; Lee, YR; Noh, SK; Park, PH; Thapa, D	1

Other Studies

1 other study(ies) available for dronabinol and Angiogenesis, Pathologic

Article	Year
Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia-inducible factor-1α activation. Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:6 Topics: Angiogenesis Inhibitors; Animals; Chickens; Chorioallantoic Membrane; Colorectal Neoplasms; Cyclooxygenase 2; Dronabinol; HT29 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2012

Article

Year

Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia-inducible factor-1α activation.

Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:6

Topics: Angiogenesis Inhibitors; Animals; Chickens; Chorioallantoic Membrane; Colorectal Neoplasms; Cyclooxygenase 2; Dronabinol; HT29 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2012